Mona Al-Gizawiy

Medical College of Wisconsin — United States

Medicine · Health Sciences

13h-index505citations43works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(23), Radiomics and Machine Learning in Medical Imaging(7), Cancer, Hypoxia, and Metabolism(6), Cancer Research and Treatments(6), MicroRNA in disease regulation(4)

Publications43 total

EXTH-134. The <i>oral</i> iron mimetic gallium maltolate is neurologically safe in a rat xenograft model of glioblastoma: multimodal assessment
Neuro-Oncology·2025Open Access
Multimodal imaging to assess treatment effect of a new therapy for glioblastoma in vivo
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2025
Potential use of iTB Maps to Distinguish GBM Recurrence from Pseudoprogression Based on Performance in the Context of Tumor Infiltration
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2025
Pharmacogenomic diversity of clinically significant cancer treatment biomarkers in ancestrally diverse US population.
Journal of Clinical Oncology·2024
Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma
Frontiers in Oncology·2024· 7 citedOpen Access
CTNI-57. PRELIMINARY RESULTS OF A PHASE 1 TRIAL OF ORAL GALLIUM MALTOLATE IN RECURRENT GLIOBLASTOMA
Neuro-Oncology·2023· 2 citedOpen Access
The Utility of Virtual Biopsies for Dataset Augmentation as Applied to AI-Based Detection of Tumor Infiltration in Non-Enhancing Brain Lesion
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2023
TIPS-03 A PHASE 1 STUDY OF GALLIUM MALTOLATE (GAM) IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM)
Neuro-Oncology Advances·2023Open Access
HGG-06. CHARACTERIZATION OF THE EFFECT OF THE ORAL IRON-MIMETIC GALLIUM MALTOLATE ON PEDIATRIC GLIOBLASTOMA GROWTH IN VIVO
Neuro-Oncology·2023Open Access
ATRT-03. THE ORAL IRON-MIMETIC GALLIUM MALTOLATE INHIBITS ATRT IN VIVO – IMAGING AND HISTOLOGICAL CHARACTERIZATION
Neuro-Oncology·2023Open Access
EXTH-16. THE ORAL IRON-MIMETIC GALLIUM MALTOLATE SUPPRESSES TREATMENT-RESISTANT GLIOBLASTOMA – IN VIVO VALIDATION
Neuro-Oncology·2022Open Access
Basal Ganglia Iron Content Increases with Glioma Severity Using Quantitative Susceptibility Mapping: A Potential Biomarker of Tumor Severity
Tomography·2022· 11 citedOpen Access
TMOD-25. IN VIVO MODEL OF TREATMENT-RESISTANT GLIOBLASTOMA HIGHLIGHTS SEX DIFFERENCES IN SURVIVAL
Neuro-Oncology·2020Open Access
The cytotoxicity of gallium maltolate in glioblastoma cells is enhanced by metformin through combined action on mitochondrial complex 1
Oncotarget·2020· 16 citedOpen Access
THER-12. NOVEL IRON-TARGETED THERAPY IS HIGHLY EFFECTIVE IN TREATMENT-RESISTANT HIGH-GRADE GLIOMA IN VIVO
Neuro-Oncology·2019Open Access
HGG-05. GALLIUM MALTOLATE AS TREATMENT IN PEDIATRIC GLIOMA
Neuro-Oncology·2019Open Access
EXTH-48. ORAL GALLIUM MALTOLATE IMPAIRS TUMOR GROWTH AND EXTENDS DISEASE-SPECIFIC SURVIVAL IN A XENOGRAFT MODEL OF RECURRENT GBM
Neuro-Oncology·2018Open Access
Irradiation of pediatric glioblastoma cells promotes radioresistance and enhances glioma malignancy<i>via</i>genome-wide transcriptome changes
Oncotarget·2018· 15 citedOpen Access
HGG-14. IRRADIATION OF PEDIATRIC GLIOBLASTOMA CELLS INDUCES DOWNREGULATION OF TUMOR SUPPRESSOR MICRORNA GENES AND UPREGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)
Neuro-Oncology·2018Open Access
Identification of radiation responsive genes and transcriptome profiling via complete RNA sequencing in a stable radioresistant U87 glioblastoma model
Oncotarget·2018· 28 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Kathleen M. Schmainda(38), Christopher R. Chitambar(27), Jennifer Connelly(17), Shama P. Mirza(16), Hisham Alhajala(13), Robert Wujek(13), Melissa Prah(12), Wade M. Mueller(11), Ninh Doan(10), Ha Son Nguyen(5), Jeffrey Knipstein(5), Scott D. Rand(4), Casey Zoss(4), Elizabeth J. Cochran(3), John S. Kuo(3), Kimberly R. Pechman(3), Janine P. Wereley(3), Ninh Doan(3), Salvatore Molino(3), Paul A. Clark(2)